Literature DB >> 16566286

Viral and non-viral methods for gene transfer into skeletal muscle.

Dominic J Wells1.   

Abstract

Skeletal muscle is an important target for genetic manipulation and its stable post-mitotic nature allows the use of both integrating and non-integrating viral and non-viral vectors. Adeno-associated viral vectors and naked plasmid DNA are currently the vectors of choice for gene transfer into muscle. The last couple of years have seen major breakthroughs in the field of vector delivery systems, particularly those using the vascular route, such that gene therapy of muscular dystrophies and the use of muscle as a platform for the production of secreted proteins has become a clinical possibility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16566286

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  4 in total

1.  A method to facilitate and monitor expression of exogenous genes in the rat kidney using plasmid and viral vectors.

Authors:  Peter R Corridon; George J Rhodes; Ellen C Leonard; David P Basile; Vincent H Gattone; Robert L Bacallao; Simon J Atkinson
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-06

2.  Targeted gene transfer into head and neck squamous cell carcinoma by nanosecond pulsed laser-induced stress waves.

Authors:  Koji Araki; Daisuke Mizokami; Nobuaki Tanaka; Hiroshi Suzuki; Shunichi Sato; Akihiro Shiotani
Journal:  Lasers Med Sci       Date:  2013-04-24       Impact factor: 3.161

3.  Long term expression of bicistronic vector driven by the FGF-1 IRES in mouse muscle.

Authors:  Camille Allera-Moreau; Aurélie Delluc-Clavières; Caroline Castano; Loïc Van den Berghe; Muriel Golzio; Marc Moreau; Justin Teissié; Jean-François Arnal; Anne-Catherine Prats
Journal:  BMC Biotechnol       Date:  2007-10-28       Impact factor: 2.563

4.  Definition of a Novel Plasmid-Based Gene Transfection Protocol of Mammalian Skeletal Muscles by Means of In Vivo Electroporation.

Authors:  Enrico P Spugnini; Manuel Scimeca; Bruno Amadio; Giancarlo Cortese; Maurizio Fanciulli; Bruno Vincenzi; Antonio De Luca; Alfonso Baldi
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.